Superbrewed Food Launches Shelf-Stable Thryvia Postbiotic
New Castle, Delaware, August 19, 2026 Superbrewed Food, Inc. has announced the commercial launch of Thryvia™, a shelf-stable, protein-derived...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Food & Dietary Supplements
New Castle, Delaware, August 19, 2026 Superbrewed Food, Inc. has announced the commercial launch of Thryvia™, a shelf-stable, protein-derived...
New Delhi, India & New York, United States, August 19, 2026 Zeon Lifesciences, an India-based nutraceutical manufacturer, has strengthened...
Abbott Park, Illinois and Bethesda, Maryland, August 17, 2026 Abbott and the National Association of Community Health Centers (NACHC)...
COPENHAGEN, Denmark, August 12, 2026 Novonesis announced the launch of Optiva® Triticum, a new biosolution designed to help pasta...
TOKYO, July 22, 2026 Kirin Holdings Company, Limited and Blackmores Limited have announced the launch of two new Cognizin®...
WASHINGTON, D.C., July 22, 2026 The U.S. Food and Drug Administration (FDA) has announced two significant regulatory actions aimed...
BALTIMORE, July 17, 2026 Medifast, Inc. has announced the launch of Trilivy™, a comprehensive science-backed metabolic health system that...
PASADENA, Texas, July 15, 2026 Kaneka Nutrients has announced the third phase of its independent Ubiquinol authenticity testing program,...
MISSION VIEJO, Calif., June 20, 2026 Kyowa Hakko USA has unveiled promising new research demonstrating the potential acute cognitive...
MELVILLE, N.Y., June 11, 2026 Certified Group announced that the U.S. Food and Drug Administration (FDA) has accepted the...
